Current study investigated multiplicative risk factors that influence kidney disease mortality over 25 years in U.S.. According to our findings, race, age, drinking, smoking, hypertension, and diabetes at baseline predicted deaths due to renal disease. Findings are unique as we used a nationally-representative sample of U.S. adults.
In line with previous research that has shown demographic groups may differ in epidemiology and course of CKD (
17), we showed that age and race influences which Americans die from renal disease. In United States, race is a main determinant of mortality due to renal diseases (
7,
18). Blacks have highest rates and burden of CKD compared to any other racial group (
7,
19). Compared to Whites, Blacks are 3-4 times more likely to develop kidney failure (
18).
In our study, Blacks were at higher risk of renal disease mortality. Ironically, there are previous studies that have documented better survival and lower psychological distress among Blacks with CKD when compared to Whites, despite their higher number of medical comorbidities as well as more severe CKD (
47).
Similar to our finding, age is also shown as a main determinant of CKD, as CKD is more common among elderly (
8,
9). In our study, however, gender did not show an independent effect on outcome. Gender is shown to be another major determinant of CKD (
10,
20). More men than women develop ESRD every year, requiring renal replacement therapy (
21). In United States, from 96,295 patients who initiated ESRD therapy in 2001, 54% were men and 46% were women (
21).
In our study, education, income and employment did not stay as independent predictors of renal disease mortality, while all other risk factors are considered. Although low socioeconomic status is a determinant of CKD (
11), their effects may be due to medical and behavioral risk factors (
7). Economic and social disadvantage and low resources operate as a distal determinant and increase the burden of CKD (
14,
22) possibly through increasing risk of diabetes, hypertension, and obesity, smoking, and lack of exercise.
In our study, drinking and smoking were predictive of renal disease mortality, however, exercise did not independently predict the same outcome. Role of life style as a modifiable determinant of CKD is known (
12,
23). In line with our findings, smoking also increases the risk of CKD, particularly those classified as hypertensive nephropathy (OR = 2.85) and diabetic nephropathy (OR = 2.24). When compared to nonsmokers, current smokers have an increased risk of having CKD (OR = 1.63), while former smokers did not have a statistically significant difference. The CKD risk associated with smoking is dosage dependent and OR for smokers with > 30 pack-years reaches 2.6. (
27). Although not supported by our study, exercise may protect against CKD (
23-
26).
We could also replicate the literature on medical and clinical factors of CKD (
13). Similar to our study, hypertension (
13) and diabetes (
28) are shown to shape risk of CKD. We could not however, replicate the effect of obesity, as its effect may not be independent but via hypertension and diabetes (
29,
30). We also did not find role of depression as a predictor of renal disease mortality, however, depression is shown to have a role previously (
6,
37).
We also did not show that SRH predicts renal disease mortality, while diabetes, hypertension, and other risk factors are controlled. SRH is shown to predict all-cause (
31), cardiovascular (
32), cancer (
33), and stroke (
34), and renal (
35) mortality. Although SRH predicts outcomes associated with renal diseases (
36), this effect may be due to other risk factors that we controlled for.
SRH has previously shown to predict renal and all-cause mortality across diverse populations (
48). While some studies suggest that contextual factors such as race and ethnicity alter the effect of SRH on mortality (
49,
50), some other studies have suggested that SRH universally predicts mortality across populations, irrespective of population and geographic region (
51,
52).
5.1. Limitations
This study has a few limitations. First and foremost, we did not have any measure of baseline kidney disease, and only used a limited number of medical risk factors at baseline. We relied on self-reported data to measure hypertension and diabetes that may be subjected to recall bias (
53). Future research should also validate self-reported chronic medical conditions using medical record data. Future research should specifically measure baseline and progression of kidney disease as well as biological measures of kidney function. In addition, while all risk factors are subject to change over time, their change was not modeled in this study. This approach was taken because we were interested in the long term effects of demographic, social, behavioral, and medical risk factors of renal disease mortality in the U.S..Despite these limitations, the results extend our current understanding regarding in predictors of mortality due to renal disease (
54-
56). Main strengths of this study include using a nationally representative sample, large sample size, and long term- follow up all needed to study rare outcomes such as death due to renal diseases.
5.2. Conclusions
A number of baseline factors such as race, age, drinking, smoking, hypertension, and diabetes predict death due to renal disease over a 25-year period in United States. These findings can be used for programming as well as planning to reduce death due to renal diseases particularly among socially disadvantaged populations in the U.S.